Using a special PET scan for pituitary tumors with unclear MRI
Part of Hormones & metabolism clinical trials.
This trial uses a special type of PET scan (18FET PET) to help find active pituitary tumors when standard MRI images are not clear. This could help doctors decide the best next step, like surgery or radiation, for people with certain hormone-producing tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a suspected or known active pituitary adenoma (a tumor that makes hormones), whether it's new or has come back.
- Your MRI results are not clear or do not show the tumor well.
- You are covered by social security in France.
- You are willing to follow the study procedures and timeline.
- You are potentially a candidate for surgery or radiation therapy if the PET scan is positive.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special type of brain scan (PET-MRI) to better find tiny pituitary tumors causing Cushing's disease. It may help people whose standard MRI didn't show a clear tumor.
This study tests a new type of PET/MRI scan that uses a special tracer (18F-FET) to better find small pituitary tumors that didn't show up on a standard MRI. The goal is to help guide surgery to remove the tumor.
This study uses a special PET scan (18F-FET) to get clearer images of pituitary adenomas (non-cancerous growths at the base of the brain). It is for people who have already had one type of PET scan and can help doctors understand the tumor better without invasive procedures.
This study uses a special PET scan (FET PET/CT) to help find tiny pituitary tumors causing Cushing disease. The goal is to improve surgery planning so the tumor can be removed successfully.
This trial uses a special PET scan to see if a new imaging agent can find hard-to-treat pituitary tumors that have come back after surgery. It may help doctors decide the best way to manage these tumors.
This study tests a special imaging agent called fluoroethyltyrosine (FET) to see if it can better detect brain tumors on PET scans. It may help doctors decide if a tumor has come back after treatment or better guide initial biopsy or surgery.
Hear when a new Functional Pituitary Adenomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.